MONGINI, Tiziana Enrica
 Distribuzione geografica
Continente #
NA - Nord America 1.632
EU - Europa 858
AS - Asia 350
OC - Oceania 28
AF - Africa 19
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.905
Nazione #
US - Stati Uniti d'America 1.584
IT - Italia 288
DE - Germania 236
CN - Cina 128
FR - Francia 104
GB - Regno Unito 56
IN - India 43
CA - Canada 41
JP - Giappone 36
VN - Vietnam 35
HK - Hong Kong 27
FI - Finlandia 26
AU - Australia 25
PL - Polonia 25
UA - Ucraina 25
KR - Corea 19
TR - Turchia 17
NL - Olanda 14
SG - Singapore 12
BR - Brasile 11
RU - Federazione Russa 11
ZA - Sudafrica 11
AT - Austria 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
IL - Israele 9
EG - Egitto 8
ES - Italia 7
MX - Messico 7
SE - Svezia 7
TW - Taiwan 7
GR - Grecia 6
IE - Irlanda 6
BE - Belgio 5
PT - Portogallo 4
IR - Iran 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
TH - Thailandia 1
Totale 2.905
Città #
Fairfield 184
Houston 116
Buffalo 98
Santa Cruz 90
Ashburn 86
Torino 86
Woodbridge 80
Seattle 77
Columbus 76
Cambridge 68
Wilmington 59
Ann Arbor 58
Mountain View 38
Beijing 33
Turin 29
University Park 28
Dong Ket 27
Nürnberg 24
Warsaw 23
Guangzhou 22
Milan 20
Pisa 20
Chicago 19
Shanghai 17
Kharkov 16
Las Vegas 15
Rome 14
Central District 13
Clearwater 12
Helsinki 12
Leawood 12
Lappeenranta 11
Los Angeles 11
Melbourne 11
Atlanta 10
San Diego 10
Henderson 9
Muizenberg 9
New York 9
Ottawa 9
Phoenix 9
Encino 8
Wuhan 8
Istanbul 7
Taipei 7
Toronto 7
Boston 6
Dallas 6
Duncan 6
Lake Forest 6
Provo 6
San Jose 6
Basaksehir 5
Bengaluru 5
Brisbane 5
Dearborn 5
Fleming Island 5
Genova 5
Hangzhou 5
Munich 5
New Haven 5
San Francisco 5
Singapore 5
St Louis 5
Amsterdam 4
Arlington 4
Berlin 4
Chengdu 4
Durham 4
Easton 4
Gainesville 4
Hanoi 4
Hobart 4
Jinan 4
Paris 4
Prineville 4
Somerville 4
Tel Aviv 4
Tokyo 4
Basel 3
Brasília 3
Bridgewater 3
Büdelsdorf 3
Changchun 3
Cheadle Hulme 3
Des Moines 3
Dublin 3
Ferrara 3
Gurgaon 3
Jacksonville 3
Latina Scalo 3
Leeds 3
Livorno 3
London 3
Madison 3
Noale 3
North Bergen 3
Nuremberg 3
Padova 3
Suzhou 3
Totale 1.826
Nome #
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy, file e27ce427-b401-2581-e053-d805fe0acbaa 318
Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy, file e27ce42c-9136-2581-e053-d805fe0acbaa 279
Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach, file e27ce42f-47f6-2581-e053-d805fe0acbaa 277
Prevalence of congenital muscular dystrophy in Italy: A population study, file e27ce42a-5a32-2581-e053-d805fe0acbaa 206
Genotype-phenotype correlation in Pompe disease, a step forward, file e27ce427-0447-2581-e053-d805fe0acbaa 196
Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy, file e27ce42a-8191-2581-e053-d805fe0acbaa 191
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy, file e27ce42a-229e-2581-e053-d805fe0acbaa 185
The empowerment of translational research: lessons from laminopathies, file e27ce427-cfc8-2581-e053-d805fe0acbaa 183
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients, file e27ce42a-229c-2581-e053-d805fe0acbaa 183
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes., file e27ce426-f370-2581-e053-d805fe0acbaa 177
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes., file e27ce427-0445-2581-e053-d805fe0acbaa 153
Assessing cognitive function in neuromuscular diseases: A pilot study in a sample of children and adolescents, file e27ce433-db29-2581-e053-d805fe0acbaa 102
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation., file e27ce42a-8f95-2581-e053-d805fe0acbaa 90
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry, file e27ce432-5b01-2581-e053-d805fe0acbaa 67
Movement disorders in children with a mitochondrial disease: A cross-sectional survey from the nationwide italian collaborative network of mitochondrial diseases, file e27ce435-19df-2581-e053-d805fe0acbaa 63
A man with fever and bilateral limb weakness, file e27ce42e-db00-2581-e053-d805fe0acbaa 28
Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea, file e27ce432-5ecf-2581-e053-d805fe0acbaa 20
Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review, file e27ce435-412b-2581-e053-d805fe0acbaa 17
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data, file e27ce432-f365-2581-e053-d805fe0acbaa 16
Wearable Inertial Devices in Duchenne Muscular Dystrophy: A Scoping Review, file 49e8fa69-5d18-46cb-a995-bd6dce416a42 15
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey, file d2c54c37-7810-4af7-8aa4-46a46670f6cb 15
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing, file e27ce434-8b91-2581-e053-d805fe0acbaa 15
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up, file e27ce432-c942-2581-e053-d805fe0acbaa 14
Adult-onset mitochondrial movement disorders: a national picture from the Italian Network, file e27ce435-19dd-2581-e053-d805fe0acbaa 14
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"?, file e27ce435-43ee-2581-e053-d805fe0acbaa 14
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements, file e27ce435-50be-2581-e053-d805fe0acbaa 13
A case of histological diagnosis of Toxoplasma gondii myositis in a person living with HIV, file 6a90d592-ec99-400f-a5f6-29f746daf95b 12
Longitudinal effect of eteplirsen vs. historical control on ambulation in DMD, file e27ce432-5ece-2581-e053-d805fe0acbaa 12
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53, file e27ce432-c7b0-2581-e053-d805fe0acbaa 11
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase, file e27ce432-f9b6-2581-e053-d805fe0acbaa 11
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report, file d12f10c8-275c-418f-8c14-35e30d2538ae 10
A Schematic Approach to Defining the Prevalence of COL VI Variants in Five Years of Next-Generation Sequencing, file 8d5d53b1-b2c0-46a6-88bc-b94920e33e8a 9
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study, file e27ce435-43f0-2581-e053-d805fe0acbaa 9
Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study, file 5863568f-a8f4-4444-8d6d-3658ed47100b 7
Biochemical characterization on muscle tissue of a novel biallelic ACO2 mutation in an infant with progressive encephalopathy, file 44439c86-4e8d-4cc2-b1f3-80f3d6f805d4 6
Improving Recognition of Treatable Rare Neuromuscular Disorders in Primary Care: A Pilot Feasibility Study, file 5437494f-317e-4327-9ce1-2af1a68edf6b 6
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?, file d3a49a95-422a-4ed2-b3af-9023b742bb7c 6
Motor Outcome Measures in Pediatric Patients with Congenital Muscular Dystrophies: A Scoping Review, file 162ebb3f-0cae-4e2c-ab74-fbf56f7b8380 5
Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach, file e27ce432-5770-2581-e053-d805fe0acbaa 4
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy., file e27ce427-b407-2581-e053-d805fe0acbaa 3
Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures, file e27ce427-d02e-2581-e053-d805fe0acbaa 3
Enzyme Replacement Therapy Improves Respiratory Outcomes in Patients with Late-Onset Type II Glycogenosis and High Ventilator Dependency., file e27ce427-d8d8-2581-e053-d805fe0acbaa 3
Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders., file e27ce427-d9cf-2581-e053-d805fe0acbaa 3
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD), file e27ce432-5ed1-2581-e053-d805fe0acbaa 3
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy, file e27ce432-a36d-2581-e053-d805fe0acbaa 3
Myoclonus in mitochondrial disorders., file e27ce426-f36e-2581-e053-d805fe0acbaa 2
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype, file e27ce427-d201-2581-e053-d805fe0acbaa 2
EFNS review on the role of muscle biopsy in the investigation of myalgia., file e27ce427-de9d-2581-e053-d805fe0acbaa 2
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?, file e27ce427-dea0-2581-e053-d805fe0acbaa 2
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study., file e27ce427-dfe9-2581-e053-d805fe0acbaa 2
Undiagnosed myopathy before surgery and safe anaesthesia table., file e27ce427-e1bd-2581-e053-d805fe0acbaa 2
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency., file e27ce428-09a2-2581-e053-d805fe0acbaa 2
Response to a letter to the editor, file e27ce42f-394f-2581-e053-d805fe0acbaa 2
Functional assessment tools in children with Pompe disease: A pilot comparative study to identify suitable outcome measures for the standard of care, file e27ce432-9c66-2581-e053-d805fe0acbaa 2
Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy, file e27ce432-c944-2581-e053-d805fe0acbaa 2
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy?, file e27ce432-ce84-2581-e053-d805fe0acbaa 2
Early higher dosage of alglucosidase alpha in classic Pompe disease, file e27ce432-dcff-2581-e053-d805fe0acbaa 2
Suitability of external controls for drug evaluation in Duchenne muscular dystrophy, file 0dfe76c9-bd7a-4092-b413-c0b31c9db766 1
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy., file e27ce426-f36f-2581-e053-d805fe0acbaa 1
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation., file e27ce426-f765-2581-e053-d805fe0acbaa 1
Vaccination recommendations for patients with neuromuscular disease., file e27ce427-0446-2581-e053-d805fe0acbaa 1
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation., file e27ce427-b5c4-2581-e053-d805fe0acbaa 1
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy., file e27ce427-cd2f-2581-e053-d805fe0acbaa 1
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis., file e27ce427-dd5c-2581-e053-d805fe0acbaa 1
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases., file e27ce427-ef54-2581-e053-d805fe0acbaa 1
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII), file e27ce428-0f53-2581-e053-d805fe0acbaa 1
New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges, file e27ce42e-c397-2581-e053-d805fe0acbaa 1
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population, file e27ce432-5ed0-2581-e053-d805fe0acbaa 1
Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry, file e27ce432-bbb9-2581-e053-d805fe0acbaa 1
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements, file e27ce432-bbbb-2581-e053-d805fe0acbaa 1
Totale 3.014
Categoria #
all - tutte 6.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201970 0 0 0 0 0 0 0 0 0 0 0 70
2019/2020550 45 49 32 78 48 53 36 51 61 33 26 38
2020/2021467 29 39 23 50 38 42 41 32 41 49 44 39
2021/2022607 70 39 43 72 55 27 33 31 34 37 118 48
2022/2023417 18 29 108 60 44 28 28 17 21 27 21 16
2023/2024350 15 12 28 15 23 10 44 33 15 35 91 29
Totale 3.014